Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported

被引:43
|
作者
Card, Timothy R. [1 ,2 ]
Langan, Sinead M. [3 ]
Chu, Thomas P. C. [1 ]
机构
[1] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England
[2] Univ Nottingham, Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham, England
[3] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England
关键词
Inflammatory bowel diseases; Epidemiology; Arthritis; Iritis; Pyoderma; PRACTICE RESEARCH DATABASE; EXTRAINTESTINAL MANIFESTATIONS; ULCERATIVE-COLITIS; ASSOCIATION; FREQUENCY; VALIDITY; RISK;
D O I
10.1007/s10620-016-4195-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Extra-intestinal manifestations are well recognized in inflammatory bowel disease (IBD). To what extent the commonly recognized extra-intestinal manifestations seen in IBD patients are attributable to IBD is, however, not clear due to the limited number of controlled studies published. We have conducted a study of these manifestations using electronic primary care records. We have identified extra-intestinal manifestations in IBD and non-IBD patients and derived odds ratios (ORs) using conditional logistic regression. A total of 56,097 IBD patients (32.5 % Crohn's disease, 48.3 % ulcerative colitis (UC) and 19.2 % not classified) were matched to 280,382 non-IBD controls. We found records of pyoderma gangrenosum (OR = 29.24), erythema nodosum (OR = 5.95), primary sclerosing cholangitis (OR = 188.25), uveitis (OR = 2.81), ankylosing spondylitis (OR = 7.07), sacroiliitis (OR = 2.79) and non-rheumatoid inflammatory arthritides (OR = 2.66) to be associated with IBD. One or more of these was recorded in 8.1 % of IBD patients and 2.3 % of controls. Non-specific arthritides were present in many more patients, affecting 30 % of IBD patients and 23.8 % of controls overall. We also found weaker associations with a number of conditions not generally considered to be extra-intestinal manifestations including psoriasis, ischemic heart disease, multiple sclerosis and hay fever. Although "classical" extra-intestinal manifestations are strongly associated with IBD, most IBD patients remain unaffected. Arthropathies, perceived to be the commonest extra-intestinal manifestation, are not strongly associated with IBD, and the proportion of arthropathies attributable to IBD is likely to be small.
引用
收藏
页码:2619 / 2626
页数:8
相关论文
共 50 条
  • [21] Gastrointestinal Manifestations in Patients With Inflammatory Bowel Disease and Novel Coronavirus Infection
    Joshi, Tejas V.
    Bilalis, Matoula V.
    Engel, Lee S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1212 - S1212
  • [22] Divergent Morphology in Renal Pelvic Urothelial Carcinoma May Be Less Frequent Than Previously Reported
    Kao, C-S
    Idrees, M.
    LABORATORY INVESTIGATION, 2012, 92 : 216A - 217A
  • [23] Divergent Morphology in Renal Pelvic Urothelial Carcinoma May Be Less Frequent Than Previously Reported
    Kao, C-S
    Idrees, M.
    MODERN PATHOLOGY, 2012, 25 : 216A - 217A
  • [24] PREDICTORS OF DEVELOPING MULTIPLE EXTRA-INTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE
    Alizadeh, Madeline
    Motwani, Kiran
    Cross, Raymond
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S29 - S29
  • [25] UNUSUAL EXTRA-INTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL-DISEASE (IBD)
    ALROY, GG
    KURSBAUM, A
    POSTGRADUATE MEDICAL JOURNAL, 1978, 54 (638) : 840 - 842
  • [26] Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease
    Eksteen, B
    Miles, AE
    Grant, AJ
    Adams, DH
    CLINICAL MEDICINE, 2004, 4 (02) : 173 - 180
  • [27] Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease
    Guru Trikudanathan
    Preethi G. K. Venkatesh
    Udayakumar Navaneethan
    Drugs, 2012, 72 : 2333 - 2349
  • [28] The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease
    Katsanos, Konstantinos H.
    Fousekis, Fotios S.
    Armuzzi, Alessandro
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (02) : 149 - 150
  • [29] Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease
    Trikudanathan, Guru
    Venkatesh, Preethi G. K.
    Navaneethan, Udayakumar
    DRUGS, 2012, 72 (18) : 2333 - 2349
  • [30] Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?
    Quigley, Eamonn M. M.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (02): : 199 - 212